Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2212 (LINC02212)

Target
LINC02212
Molecular classification
Long non-coding RNA (lncRNA), Intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2212 (LINC02212) is a long non-coding RNA (lncRNA) that does not encode a protein and is transcribed from intergenic regions of the genome[1][5]. LINC02212 is implicated in the regulation of gene expression, most notably by acting as an enhancer, recruiting transcription factors, and regulating alternative splicing events[3]. It displays altered expression levels in several cancer types, particularly cholangiocarcinoma, kidney renal clear cell carcinoma, and kidney renal papillary cell carcinoma, where it is found to be upregulated in tumor tissue compared to normal tissue[3]. While long intergenic non-coding RNAs in general are known to participate in various aspects of cellular regulation, the specific functional or therapeutic targeting and detailed mechanisms for LINC02212 remain largely uncharacterized in current public data[1][3][5][7].

Other names
LINC02212RP11-1C1.405p15.2
02

Biological functions

Gene regulationEnhancer-like functionAlternative splicing regulationRecruitment of transcription factors
03

Disease associations

Cancer (notably cholangiocarcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma)
04

Biomarkers

Potential biomarker for specific cancers, based on differential expression

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2212 (LINC02212).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2212 (LINC02212).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call